Literature DB >> 12354773

HIV Nef inhibits T cell migration.

Evangeline Y Choe1, Elena S Schoenberger, Jerome E Groopman, In-Woo Park.   

Abstract

Nef is a viral regulatory protein of the human immunodeficiency virus (HIV) that has been shown to contribute to disease progression. Among its putative effects on T cell functions are the down-regulation of CD4 and major histocompatibility class I surface molecules. These effects occur in part via Nef interactions with intracellular signaling molecules. We sought to better characterize the effects of HIV Nef on T cell function by examining chemotaxis in response to stromal cell-derived factor-1alpha (SDF-1alpha) as well as CXCR4 signaling molecules. Here, we report the novel observation that HIV Nef inhibited chemotaxis in response to SDF-1alpha in both Jurkat T cells and primary peripheral CD4+ T lymphocytes. Our data indicate that HIV Nef altered critical downstream molecules in the CXCR4 pathway, including focal adhesion kinases. These findings suggest that HIV Nef may blunt the T cell response to chemokines. Because T lymphocyte migration is an integral component of host defense, HIV Nef may thereby contribute to the pathogenesis of AIDS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12354773     DOI: 10.1074/jbc.M204698200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Recent Insights into HIV Accessory Proteins.

Authors:  Jenny L. Anderson; Thomas J. Hope
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.725

Review 2.  HIV-1 and the hijacking of dendritic cells: a tug of war.

Authors:  Marie Larsson
Journal:  Springer Semin Immunopathol       Date:  2005-01

Review 3.  HIV accessory proteins and surviving the host cell.

Authors:  Jenny L Anderson; Thomas J Hope
Journal:  Curr HIV/AIDS Rep       Date:  2004-04       Impact factor: 5.071

4.  SDF-1alpha is a potent inducer of HIV-1-Specific CD8+ T-cell chemotaxis, but migration of CD8+ T cells is impaired at high viral loads.

Authors:  Amie L Meditz; Rick Schlichtemeier; Joy M Folkvord; Monique Givens; Kevin C Lesh; M G Ray; Martin D McCarter; Elizabeth Connick
Journal:  AIDS Res Hum Retroviruses       Date:  2008-07       Impact factor: 2.205

5.  HIV-1 Nef CAWLEAQ motif: a regulator of monocytes invasion through ENO1 modulation.

Authors:  Reshu Saxena; Umesh Kumar Vekariya; Pradeep Kumar; Amit Kumar Tripathi; Jimut Kanti Ghosh; Raj Kamal Tripathi
Journal:  Mol Cell Biochem       Date:  2018-02-05       Impact factor: 3.396

Review 6.  Adding new dimensions: towards an integrative understanding of HIV-1 spread.

Authors:  Oliver T Fackler; Thomas T Murooka; Andrea Imle; Thorsten R Mempel
Journal:  Nat Rev Microbiol       Date:  2014-08       Impact factor: 60.633

7.  HIV-1 Nef impairs heterotrimeric G-protein signaling by targeting Gα(i2) for degradation through ubiquitination.

Authors:  Prabha Chandrasekaran; Monica Buckley; Victoria Moore; Long Qin Wang; John H Kehrl; Sundararajan Venkatesan
Journal:  J Biol Chem       Date:  2012-10-15       Impact factor: 5.157

8.  HIV-1 Nef interferes with T-lymphocyte circulation through confined environments in vivo.

Authors:  Bettina Stolp; Andrea Imle; Fernanda Matos Coelho; Miroslav Hons; Roser Gorina; Ruth Lyck; Jens V Stein; Oliver T Fackler
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-23       Impact factor: 11.205

9.  HIV-1 Nef inhibits ruffles, induces filopodia, and modulates migration of infected lymphocytes.

Authors:  Cinzia Nobile; Dominika Rudnicka; Milena Hasan; Nathalie Aulner; Françoise Porrot; Christophe Machu; Olivier Renaud; Marie-Christine Prévost; Claire Hivroz; Olivier Schwartz; Nathalie Sol-Foulon
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

10.  Modulation of HIV pathogenesis and T-cell signaling by HIV-1 Nef.

Authors:  Shailendra K Saxena; Gaurav Shrivastava; Sneham Tiwari; Ml Arvinda Swamy; Madhavan Pn Nair
Journal:  Future Virol       Date:  2012-06-01       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.